CFDE Data Portal | Search SPATA3-AS1

	Label	Description
	SPATA3-AS1 associations Collection (Entity type)	Associations for SPATA3-AS1_associations
	SPATA3-AS1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	SPATA3-AS1 Gene (Entity type)	ENSG00000238062 - SPATA3 antisense RNA 1
	GSE195663 cisplatin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE195663 cisplatin 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216988 GSE216989 decitabine 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE228017 parthenolide 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE143782 calcitriol 3 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE85880 GSE85881 tretinoin cardiac muscle cell 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE95685 2 V 3 TCPOBOP MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS

SPATA3-AS1 associations

Associations for SPATA3-AS1_associations

SPATA3-AS1 associations.tsv

A file from IDG as part of the Harmonizome project

SPATA3-AS1

ENSG00000238062 - SPATA3 antisense RNA 1

GSE195663 cisplatin 0 v 1 human up

A Gene Set from LINCS

GSE195663 cisplatin 0 v 3 human up

A Gene Set from LINCS

GSE216988 GSE216989 decitabine 0 v 1 human up

A Gene Set from LINCS

GSE228017 parthenolide 0 v 1 human up

A Gene Set from LINCS

GSE143782 calcitriol 3 v 4 human up

A Gene Set from LINCS

GSE85880 GSE85881 tretinoin cardiac muscle cell 4 v 1 human dn

A Gene Set from LINCS

GSE95685 2 V 3 TCPOBOP MOUSE DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.